论文部分内容阅读
1994年,李勇博士创建博德公司(长春生物制品研究所控股,吉林省科技厅投资的国有企业),经过13年艰苦奋斗,从一个10余名研究人员的实验室发展到300余员工的高科技企业;从在省科技厅立项“ABO血型单抗大规模无CO2培养新工艺”的科研资金50万及20万左右的科研设备,开始实现产业化,现发展为年销售额3000万元,总资产增值到1986万,市场占有率达80%的大型公司。
In 1994, Dr. Li Yong founded Bode Company (a state-controlled enterprise invested by Changchun Institute of Biological Products and invested by Science and Technology Department of Jilin Province). After 13 years of painstaking efforts, Dr. Li Yong developed from a laboratory of more than 10 researchers to more than 300 employees High-tech enterprises; from the provincial science and Technology Department project “ABO blood group monoclonal antibody CO2-free culture of new technology,” the research funds of 500,000 and 200,000 of scientific research equipment, began to achieve industrialization, is now developed into annual sales of 3000 Million, the total assets added to 1986 million, the market share of 80% of large companies.